Skip to content

Intrathecal Morphine for Pain Relief and Recovery After Uterine Artery Embolization

Impact of Intrathecal Morphine on Postoperative Analgesia and Quality of Recovery After Uterine Artery Embolization: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122726
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids and adenomyosis

Interventions

Intrathecal Placebo + Standard Postoperative Care:Intrathecal Placebo
Intrathecal Morphine + Standard Postoperative Care:intrathecal morphine

Sponsors

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.adult patients aged 18 to 60 years who were able to provide informed consent; American Society of Anesthesiologists (ASA) physical status I or II; 2.a diagnosis of uterine fibroids or adenomyosis scheduled for elective unilateral or bilateral uterine artery embolization; 3.body mass index (BMI) between 18 and 35 kg/m²;

Exclusion criteria

Exclusion criteria: 1.known allergy to local anesthetics, opioids, or nonsteroidal anti-inflammatory drugs; 2.cognitive or language impairment precluding participation in the study or completion of questionnaires; 3.refusal to undergo the planned procedure for any reason prior to surgery; 4.preexisting neurological disorders; 5.contraindications to neuraxial anesthesia, including infection at or near the injection site or coagulopathy (defined as an international normalized ratio >1.3 and/or a platelet count <100 × 10?/L); 6.prior opioid use before surgery; 7.and preoperative pain with a numerical rating scale (NRS) score greater than 3;

Design outcomes

Primary

MeasureTime frame
Quality of Recovery-15(24 hours after surgery);

Secondary

MeasureTime frame
Opioid consumption;patient satisfaction;time to first patient-controlled analgesia (PCA) demand;number of patient-controlled analgesia (PCA) demands;Quality of Recovery-15(2 days after surgery);Inflammatory markers;Postoperative adverse events;Numeric Rating Scale;Surgeon satisfaction;

Countries

China

Contacts

Public ContactZhang Hui

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

zhanghui@gd2h.org.cn+86 20 8916 8167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026